Attendance at pre‐pregnancy care clinics for women with type 1 diabetes: A scoping review. Issue 3 (28th November 2022)

• Record Type: Journal Article
• Authors: Ferry, Pauline; Dunne, Fidelma P.; Meagher, Catherine; Lennon, Roisin; Egan, Aoife M.; Newman, Christine
• Is Part Of: Diabetic medicine. Volume 40:Issue 3(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-11-28
• Subjects: attendance -- childbearing age -- non‐attendance -- preconception -- pre‐pregnancy -- type 1 diabetes; Diabetes -- Periodicals; 616.462
• DOI: 10.1111/dme.15014
• Languages: English
• ISSNs: 0742-3071

Abstract

Abstract: Introduction: Type 1 diabetes mellitus occurs in one in every 275 pregnancies and can result in increased morbidity and mortality for both mother and baby. Several pregnancy complications can be reduced or prevented by attendance at pre‐pregnancy care (PPC). Despite this, less than 40% of pregnant women with pre‐gestational diabetes receive formal PPC. The aim of this scoping review is to identify the barriers to PPC attendance among women with type 1 diabetes. Methods: We conducted a scoping review by searching five databases (Ebsco, Embase, Ovid and PubMed for literature and the ProQuest for any grey/unpublished literature) for studies in English between 2000 and 2022. Studies that evaluated attendance at PPC for women with type 1 diabetes were included. Results: There are multiple barriers to PPC attendance, and many of these barriers have been unchanged since the 1990s. Identified barriers can be grouped under patient‐centered and clinician‐centered headings. Patient factors include knowledge and awareness, unplanned pregnancies, negative perceptions of healthcare and communication issues, unclear attendance pathways and logistical issues including time off work and childcare. Clinician factors include physician knowledge, time constraints and lack of comfort discussing pregnancy/contraception. Conclusion: This review highlights the ongoing problem of poor attendance at PPC and identifies key barriers to be addressed when developing and implementing PPC programs for women with type 1 diabetes.